FDA Drug Application (202814) for LAMIVUDINE; ZIDOVUDINE by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number202814
Product Number001
FormTABLET, FOR SUSPENSION; ORAL
Dosage30MG; 60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; ZIDOVUDINE
Active IngredientLAMIVUDINE; ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by CIPLA LIMITED